Skip to Main Content
 
print twitter facebook instagram blogger

Home | About | Surveys | Sitemap | Shop | Contact

Treatment options > Parathyroid Hormone

Parathyroid Hormone-Teriparatide

Teriparatide (Forsteo) is recombinant parathyroid hormone and should be considered for treatment of osteoporosis in postmenopausal women who are intolerant or unresponsive to bisphosphonate therapy and are at very high risk of further fracture.
Current maximum treatment period is 18 months.

Teriparatide
(Forsteo)
250mcg/ml prefilled pen 20mcg once dailys.c. injection £271.88 for 1x2.4ml

UK Professional Area

General Home UK Home Irish Home General + Decision tree Ask us HRT + Treatment Options + Non-HRT Options for Menopausal Vasomotor Symptoms Estrogen Only Perimenopausal Patients Post menopausal patients Progestogens Testosterone Local treatments Selective estrogen receptor modulators Bisphosphonates Calcium and Vitamin D Parathyroid Hormone Calcitonin Guide to alternatives News + Useful meetings Resources Useful Statements and Summaries FORUM Sponsors